Top Markets
#1 Siacoin Siacoin +30.23%
#2 Official Trump Official Trump +27.13%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +21.19%
#4 EXOD EXOD +18.93%
#5 MowCat MowCat +18.24%
#6 Mubarak Mubarak +16.47%
#7 Melania Meme Melania Meme +16.14%
#8 Unit Pump Unit Pump +15.39%
#9 Pump.fun Pump.fun +15.39%
#10 The Bitcoin Bull The Bitcoin Bull +14.77%
Coin of the day
Siacoin Siacoin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rang in Aktien #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Aktienkurs
$19.30
Zuletzt synchronisiert: 2023-12-26
Marktkapitalisierung
$72.77M
Veränderung (1 Tag)
6.22%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Aeglea BioTherapeutics, Inc. (AGLE)

Kategorie

Healthcare
EPS für Aeglea BioTherapeutics, Inc. (AGLE)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Aeglea BioTherapeutics, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Aeglea BioTherapeutics, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH